Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
PaperCitations, authors & open-access status
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 911 citations, 2007 year and closed oa status.
911
Citations
2007
Year
closed
OA Status